What Should We Scared Of This Week?

  • by: |
  • 11/01/2011
There are two reports from ABCnews.com warning us to worry about deaths from painkillers and kids overdosing on painkillers at home (in case you didn't get the first message about deaths from painkillers).   Then Vicious Sid Wolfe is sending out press releases opposing the approval of a test to predict onset of Alzheimer's and a new blood thinner.  Both dangerous. 

Letter Urging Rejection of Florbetapir F18 Injection (Amyvid), Experimental Procedure for Diagnosing Alzheimer’s Disease

Letter Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation

The ABC News stories ignore context.  But so do the press releases and studies from the CDCP triggering this anxiety.    The CDC fails to note that the increase is concentrated among  young adults in rural areas who are also abusing other prescription painkillers and medications in combination with cocaine.  That's not a good thing but it's not an epidemic affecting everyone. 

The Wolfe inspired panic is par for the course.  For instance, Sid Wolfe opposed the approval of every oral diabetes drugs since the  1970s.

And speaking of scares:  Remember when Steve Nissen spread fear about the cardiovascular risks of using meds for ADHD. The cardiologist who knows next to nothing about treating ADHD said he wants doctor's pen to quiver before the write a scrip for a drug Nissen believes is overprescribed.  He continued the assault earlier this year when an observational study that Nissen (who specializes in running small observational studies for money) trashed as too small showed no CV risk.      http://www.cbsnews.com/8301-504763_162-20063572-10391704.html

Now a large FDA sponsored study finds no risk.  

Everything we worry about, especially when it's a risk hyped by those who are anti-innovation like Wolfe and Nissen , has to be placed in the context of previous studies, other risks, variations unique to individuals or groups.   If a risk is not discussed with such parameters in place, it is not a risk..it's a false alarm.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog